As of 2024-12-14, the EV/EBITDA ratio of Clearpoint Neuro Inc (CLPT) is -23.99. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CLPT's latest enterprise value is 430.74 mil USD. CLPT's TTM EBITDA according to its financial statements is -17.96 mil USD. Dividing these 2 quantities gives us the above CLPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 21.2x - 22.0x | 21.8x |
| Forward P/E multiples | 21.4x - 22.9x | 21.8x |
| Fair Price | (13.18) - (13.54) | (13.44) |
| Upside | -180.4% - -182.6% | -182.0% |
| Date | EV/EBITDA |
| 2024-11-29 | -17.83 |
| 2024-11-27 | -17.40 |
| 2024-11-26 | -17.17 |
| 2024-11-25 | -16.72 |
| 2024-11-22 | -16.97 |
| 2024-11-21 | -15.83 |
| 2024-11-20 | -15.63 |
| 2024-11-19 | -15.65 |
| 2024-11-18 | -15.29 |
| 2024-11-15 | -15.59 |
| 2024-11-14 | -16.06 |
| 2024-11-13 | -15.62 |
| 2024-11-12 | -15.88 |
| 2024-11-11 | -16.32 |
| 2024-11-08 | -16.69 |
| 2024-11-07 | -19.41 |
| 2024-11-06 | -19.35 |
| 2024-11-05 | -18.49 |
| 2024-11-04 | -18.36 |
| 2024-11-01 | -18.60 |
| 2024-10-31 | -17.83 |
| 2024-10-30 | -18.55 |
| 2024-10-29 | -18.79 |
| 2024-10-28 | -18.99 |
| 2024-10-25 | -18.83 |
| 2024-10-24 | -18.12 |
| 2024-10-23 | -17.67 |
| 2024-10-22 | -18.44 |
| 2024-10-21 | -19.12 |
| 2024-10-18 | -19.47 |
| 2024-10-17 | -17.32 |
| 2024-10-16 | -17.20 |
| 2024-10-15 | -17.29 |
| 2024-10-14 | -17.86 |
| 2024-10-11 | -16.63 |
| 2024-10-10 | -16.29 |
| 2024-10-09 | -17.43 |
| 2024-10-08 | -16.64 |
| 2024-10-07 | -15.39 |
| 2024-10-04 | -16.02 |
| 2024-10-03 | -15.88 |
| 2024-10-02 | -15.55 |
| 2024-10-01 | -15.40 |
| 2024-09-30 | -16.02 |
| 2024-09-27 | -15.98 |
| 2024-09-26 | -15.86 |
| 2024-09-25 | -16.11 |
| 2024-09-24 | -16.31 |
| 2024-09-23 | -16.51 |
| 2024-09-20 | -17.84 |